4.8(top 5%)
impact factor
5.1K(top 5%)
papers
251.3K(top 2%)
citations
181(top 2%)
h-index
4.9(top 5%)
impact factor
6.2K
all documents
260.8K
doc citations
296(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Hydrogels in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics20003,290
2Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics20003,078
3Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics20002,037
4Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics20041,792
5Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapyEuropean Journal of Pharmaceutics and Biopharmaceutics20151,278
6Polymeric micelles – a new generation of colloidal drug carriersEuropean Journal of Pharmaceutics and Biopharmaceutics19991,132
7In situ-forming hydrogels—review of temperature-sensitive systemsEuropean Journal of Pharmaceutics and Biopharmaceutics20041,106
8Thermoresponsive hydrogels in biomedical applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics20081,086
9Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEuropean Journal of Pharmaceutics and Biopharmaceutics20091,055
10Collagen – biomaterial for drug delivery1Dedicated to Professor Dr. Eberhard Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, on the occasion of his 70th birthday.1European Journal of Pharmaceutics and Biopharmaceutics19981,011
11A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomesEuropean Journal of Pharmaceutics and Biopharmaceutics2007967
12Polyethylenimine-based non-viral gene delivery systemsEuropean Journal of Pharmaceutics and Biopharmaceutics2005888
13Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEuropean Journal of Pharmaceutics and Biopharmaceutics2006888
14Nanoparticles for drug delivery: The need for precision in reporting particle size parametersEuropean Journal of Pharmaceutics and Biopharmaceutics2008884
15Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics2004836
16Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics1998765
17Chitosan-based drug delivery systemsEuropean Journal of Pharmaceutics and Biopharmaceutics2012755
18Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification systemEuropean Journal of Pharmaceutics and Biopharmaceutics2004678
19Recent advances on antimicrobial wound dressing: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics2018650
20Mucoadhesive polymeric platforms for controlled drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics2009625
21Melt extrusion: from process to drug delivery technologyEuropean Journal of Pharmaceutics and Biopharmaceutics2002604
22Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standardsEuropean Journal of Pharmaceutics and Biopharmaceutics2000588
23State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics2011569
24Development and bioavailability assessment of ramipril nanoemulsion formulationEuropean Journal of Pharmaceutics and Biopharmaceutics2007567
25HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of actionEuropean Journal of Pharmaceutics and Biopharmaceutics2000550
26Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?European Journal of Pharmaceutics and Biopharmaceutics2000547
27Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics2013531
28Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugsEuropean Journal of Pharmaceutics and Biopharmaceutics2007524
29Multifunctional and stimuli-sensitive pharmaceutical nanocarriersEuropean Journal of Pharmaceutics and Biopharmaceutics2009524
30Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)European Journal of Pharmaceutics and Biopharmaceutics2009516
31Current trends and future perspectives of solid dispersions containing poorly water-soluble drugsEuropean Journal of Pharmaceutics and Biopharmaceutics2013508
32Dendrimers as versatile platform in drug delivery applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics2009503
33Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEuropean Journal of Pharmaceutics and Biopharmaceutics2011493
34Nanoparticles – An efficient carrier for drug delivery into the hair folliclesEuropean Journal of Pharmaceutics and Biopharmaceutics2007488
35Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacyEuropean Journal of Pharmaceutics and Biopharmaceutics2004486
363D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tabletsEuropean Journal of Pharmaceutics and Biopharmaceutics2015464
37Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophagesEuropean Journal of Pharmaceutics and Biopharmaceutics2011461
38Inclusion of ibuprofen in mesoporous templated silica: drug loading and release propertyEuropean Journal of Pharmaceutics and Biopharmaceutics2004459
39Passive skin penetration enhancement and its quantification in vitroEuropean Journal of Pharmaceutics and Biopharmaceutics2001458
40Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinEuropean Journal of Pharmaceutics and Biopharmaceutics2000457
41Polysaccharide-decorated nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics2004441
42Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)European Journal of Pharmaceutics and Biopharmaceutics2008433
43Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics2014427
44Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phaseEuropean Journal of Pharmaceutics and Biopharmaceutics1999418
45Chitosan as a starting material for wound healing applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics2015412
46Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisationEuropean Journal of Pharmaceutics and Biopharmaceutics2007410
47Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in miceEuropean Journal of Pharmaceutics and Biopharmaceutics2004408
48Self-dispersing lipid formulations for improving oral absorption of lipophilic drugsEuropean Journal of Pharmaceutics and Biopharmaceutics2000395
49Current in vitro methods in nanoparticle risk assessment: Limitations and challengesEuropean Journal of Pharmaceutics and Biopharmaceutics2009392
50Lipid nanoparticles for parenteral delivery of activesEuropean Journal of Pharmaceutics and Biopharmaceutics2009388